Search is Powered by Google
Cancer / Oncology News

Cancer's Genetic 'Support Network' Defined

Main Category: Cancer / Oncology
Also Included In: Genetics
Article Date: 15 Feb 2008 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:3 stars

3 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Researchers at Duke University's Institute for Genome Sciences & Policy (IGSP) have developed a new method that essentially does for the genetic pathways underlying cancer what social networking web sites can do for people: It finds the connections among them.

The team reported its findings in PLoS Computational Biology on Feb. 15, 2008.

"Our major innovation is the use of gene sets in modeling tumor progression rather than single genes," said Sayan Mukherjee, an IGSP investigator and assistant professor in the department of statistical science at Duke.

The researchers first identified familiar sets of genes that work together to support the development of cancer by allowing uncontrolled growth or encouraging the development of blood vessels, for example. Then they used their new statistical techniques to look for relationships, or dependencies, that tie those separate gene sets together.

Their modeling method also enabled them to characterize gene networks as they evolve over the course of tumor progression, from normal tissue to the beginnings of cancer and on to that cancer's spread, or metastasis.

"We'd like to know why cancer goes metastatic," Mukherjee said. "Primary cancer can often be dealt with fairly well, so the real goal is to understand what happens when it spreads. My hope is that we could give these maps to a clinician and be able to tell them 'This is what it looks like.'"

That intuitive understanding of how each pathway fits into the broader context might allow physicians to more strategically select drug targets. For instance, they might target a pathway that serves as a kind of central hub, holding the rest of the network together. Or, Mukherjee said, if the genes in a particular cancer type were found to fall into isolated clusters, they might develop a combination treatment designed to hit each one.

The researchers grouped gene pathways according to the six major hallmarks of cancer:
1) self-sufficiency in growth signals,
2) insensitivity to anti-growth signals,
3) evasion of cell death,
4) limitless ability to proliferate,
5) sustained ability to grow new blood vessels and
6) the ability to invade tissues and spread.
Then they developed an analytical framework for discovering which pathways are relevant throughout a particular form of the disease and which are only active in certain stages.

The networks of genes in prostate cancer and melanoma that came out of their analysis fit well with earlier findings. "It was a surprise that we were able to recapitulate a lot of what was known," while making these broader connections, he added.

Their method can now be applied to develop models of other cancers and Mukherjee said his team is already working to unravel the pathway connections underlying colon cancer. It could also be applied in other realms, such as the study of embryonic development, he added.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Collaborators on the study include Elena Edelman and Justin Guinney, both graduate students in the Computational Biology and Bioinformatics Program, Jen-Tsan Chi, assistant professor of molecular genetics and microbiology and Phillip Febbo, assistant professor in the department of medicine. All of the researchers are at the IGSP at Duke. The work was supported by the Damon Runyon Cancer Research Foundation, the National Science Foundation and the National Institutes of Health.

Source: Kendall Morgan
Duke University




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...